ZTS Zoetis Inc

$120.82

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

As Zoetis approaches its earnings announcement on November 4, the focus is on its ability to sustain the impressive growth trajectory that has characterized its recent quarters. With a market cap of approximately $64.7 billion, Zoetis stands as a formidable player in the animal health industry, and analysts are keenly observing whether it can surpass the EPS estimate of $1.62 and revenue projection of $2.41 billion. The whisper number of $1.76 suggests that market insiders are optimistic about Zoetis's performance, potentially driven by strategic initiatives in expanding its product portfolio and enhancing its global distribution networks. Investors will be particularly interested in how these efforts translate into financial results, as Zoetis continues to leverage its strong market position to capture increased demand in both companion and livestock animal segments. The upcoming earnings report will be a critical indicator of whether Zoetis can continue to outperform expectations and maintain its momentum in a competitive landscape.

Updated On 11/16/2025

About Zoetis Inc

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

Website: https://www.zoetis.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1555280
Address
10 SYLVAN WAY, PARSIPPANY, NJ, US
Valuation
Market Cap
$66.32B
P/E Ratio
27.18
PEG Ratio
2.63
Price to Book
13.90
Performance
EPS
$5.47
Dividend Yield
1.35%
Profit Margin
26.90%
ROE
51.10%
Technicals
50D MA
$161.79
200D MA
$175.10
52W High
$199.25
52W Low
$139.70
Fundamentals
Shares Outstanding
446M
Target Price
$198.93
Beta
0.93

ZTS EPS Estimates vs Actual

Estimated
Actual

ZTS News & Sentiment

Nov 15, 2025 • Motley Fool SOMEWHAT-BULLISH
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore
These cheap dividend stocks would make great cornerstone pieces to any portfolio -- especially for investors looking for a deal in today's somewhat expensive market.
Nov 13, 2025 • Zacks Commentary BULLISH
CPRX vs. ZTS: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both Catalyst Pharmaceutical ( CPRX Quick QuoteCPRX - ) and Zoetis ( ZTS Quick QuoteZTS - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.
Nov 11, 2025 • Motley Fool NEUTRAL
2 Dividend Stocks to Double Up on Right Now
These healthcare heavyweights have tumbled, causing abnormally high dividend yields.
Nov 06, 2025 • Motley Fool NEUTRAL
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on.
Nov 04, 2025 • Benzinga NEUTRAL
Zoetis Stock Outlook Clouded By Rising Competitive Pressures - Zoetis ( NYSE:ZTS )
Animal health firm Zoetis Inc. ( NYSE:ZTS ) on Tuesday reported a third-quarter 2025 adjusted earnings per share of $1.70. The company beat the consensus of $1.62. Adjusted net income was $754 million. That's an increase of 5% on a reported basis, and a rise of 9% on an organic operational ...
Nov 04, 2025 • Zacks Commentary NEUTRAL
ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
Zoetis tops Q3 earnings forecasts but misses on revenues and trims 2025 sales outlook, sending shares lower on weak U.S. results.
Sentiment Snapshot

Average Sentiment Score:

0.311
50 articles with scored sentiment

Overall Sentiment:

Bullish

ZTS Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Pre market)
0.09 Surprise
  • Reported EPS: $1.61
  • Estimate: $1.52
  • Whisper:
  • Surprise %: 5.9%
May 06, 2025
Mar 31, 2025 (Pre market)
0.08 Surprise
  • Reported EPS: $1.48
  • Estimate: $1.40
  • Whisper:
  • Surprise %: 5.7%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $1.40
  • Estimate: $1.36
  • Whisper:
  • Surprise %: 2.9%
Nov 04, 2024
Sep 30, 2024 (Pre market)
0.12 Surprise
  • Reported EPS: $1.58
  • Estimate: $1.46
  • Whisper:
  • Surprise %: 8.2%
Aug 06, 2024
Jun 30, 2024 (Pre market)
0.07 Surprise
  • Reported EPS: $1.56
  • Estimate: $1.49
  • Whisper:
  • Surprise %: 4.7%
May 02, 2024
Mar 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $1.38
  • Estimate: $1.34
  • Whisper:
  • Surprise %: 3.0%
Feb 13, 2024
Dec 31, 2023 (Pre market)
-0.08 Surprise
  • Reported EPS: $1.24
  • Estimate: $1.32
  • Whisper:
  • Surprise %: -6.1%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.0 Surprise
  • Reported EPS: $1.36
  • Estimate: $1.36
  • Whisper:
  • Surprise %: 0.0%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.09 Surprise
  • Reported EPS: $1.41
  • Estimate: $1.32
  • Whisper:
  • Surprise %: 6.8%

Financials